Serum lipids and fatty acids in ischemic strokes

Area of Science:

• Neurology
• Biochemistry
• Cardiovascular Medicine

Background:

• Stroke is a leading cause of disability and death.
• Understanding the role of lipid profiles in stroke pathogenesis is crucial for targeted prevention and treatment strategies.
• Existing research suggests potential links between blood lipid levels and stroke risk, but age-specific variations require further investigation.

Purpose of the Study:

• To investigate the association between various blood lipid constituents and stroke across different age groups.
• To identify specific lipid biomarkers that may predict stroke development in middle-aged men.
• To explore the lipid profile differences in young patients with unexpected stroke and their response to treatment.

Main Methods:

• Lipid analysis of blood samples from patients with stroke and control groups.
• Assessment of total serum cholesterol, triglycerides, high-density lipoprotein cholesterol, cholestanol, n-6 polyunsaturated fatty acids, and platelet arachidonic acid levels.
• Comparison of lipid profiles across different age demographics (young, middle-aged, elderly).

Main Results:

• Increased triglycerides were more frequently associated with stroke in middle-aged men compared to total serum cholesterol.
• Low high-density lipoprotein cholesterol was observed in most stroke patients, except for young individuals.
• High cholestanol and low n-6 polyunsaturated fatty acids predicted stroke in middle-aged men and were found in elderly patients with multi-infarct dementia.
• Young stroke patients exhibited normal serum lipids but had reduced platelet arachidonic acid, which normalized with aspirin treatment.

Conclusions:

• The etiopathogenesis of ischemic brain damage differs significantly across age groups.
• Specific lipid abnormalities, such as high cholestanol and low n-6 polyunsaturated fatty acids, are significant predictors of stroke in middle-aged men.
• Platelet arachidonic acid deficiency may play a role in cryptogenic stroke in young adults, suggesting potential therapeutic targets.